Burosumab, CAS 1610833-03-8

Product Description: Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].

Formula: N/A

References: [1]Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children. Front Endocrinol (Lausanne). 2020 May 28;11:338./[2]Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1.

CAS Number: 1610833-03-8

Molecular Weight: N/A

Compound Purity: 96.85

Research Area: Others

Solubility: H2O

Target: Others

• SKU: MEXHY-P9939-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9939-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK